Introduction
On September 19, 2025, Kaynes Technology India Limited, a frontrunner in India's burgeoning electronics manufacturing services (EMS) sector, found itself in the spotlight for all the wrong reasons. Shares of the company plummeted over 4% in intraday trading on the BSE and NSE, closing at ₹6,940—a sharp drop from the previous day's ₹7,257. This nosedive came mere hours after the announcement that Chief Executive Officer (CEO) Rajesh Sharma had tendered his resignation, effective October 31, 2025. The news, disclosed in a regulatory filing to the exchanges, triggered a wave of investor unease, erasing nearly ₹2,500 crore from the company's market capitalization in a single session.
Rajesh Sharma, who had steered Kaynes through pivotal growth phases since joining in 2021, cited a desire to "embark on a new professional journey" in his resignation letter to the board. Under his leadership, the Mysore-headquartered firm not only navigated a successful initial public offering (IPO) in 2021 but also scaled its market cap to over ₹50,000 crore, expanded production capacities, and clinched key acquisitions both domestically and globally. Yet, the sudden exit—amid broader market turbulence fueled by global supply chain jitters and domestic inflation concerns—has cast a shadow over Kaynes' trajectory. The Nifty 50 and Sensex, already down 0.46% and 0.42% respectively on the day, amplified the sell-off, with small-cap indices like the Nifty Smallcap 100 extending losses for the fifth straight session.
This development isn't isolated; it unfolds against a backdrop of volatility in the EMS space, where companies like Kaynes grapple with semiconductor shortages, geopolitical tensions in the Taiwan Strait, and a softening demand outlook from key clients in automotive and aerospace. As investors digest the implications, questions swirl: Is Sharma's departure a symptom of deeper internal challenges, or merely a personal pivot? Will the board's swift naming of a successor stabilize sentiment? And how does this fit into Kaynes' ambitious PLI (Production Linked Incentive) scheme playbook? This in-depth analysis explores the resignation's triggers, the immediate market fallout, the company's resilient fundamentals, and the road ahead in a sector poised for explosive growth yet riddled with risks.
The Resignation Bombshell: Rajesh Sharma's Tenure and Exit
Rajesh Sharma's resignation letter, addressed to the board on September 18, 2025, was a model of corporate decorum—grateful, reflective, and forward-looking. "I am immensely thankful for the opportunity to lead Kaynes during this transformative period," he wrote, enumerating milestones like the ₹667 crore IPO in November 2021, which valued the company at ₹3,500 crore on debut and soared 184% within months. Sharma, a seasoned executive with over 25 years in manufacturing and supply chain management, joined as CEO in early 2021 from a stint at Foxconn India. His arrival coincided with India's "Make in India" push, positioning Kaynes as a key player in the EMS ecosystem.
During his nearly four-year stint, Sharma oversaw a revenue surge from ₹1,025 crore in FY21 to an estimated ₹4,500 crore in FY25, driven by diversification into high-margin segments like aerospace (Boeing partnerships) and automotive (EV componentry). He championed the acquisition of August Electronics in the US (2023, $10 million) for global footprint expansion and spearheaded the setup of a ₹1,700 crore facility in Sanand, Gujarat, under the PLI scheme for electronics. Under his watch, Kaynes' order book swelled to ₹5,200 crore by Q1 FY26, with EBITDA margins stabilizing at 13-15%.
However, Sharma's exit isn't without whispers of strain. Sources close to the company suggest boardroom debates over aggressive capex—₹2,000 crore planned for FY26—clashed with Sharma's vision for measured scaling amid supply chain volatilities. The resignation, effective October 31, leaves a six-week transition window, with Managing Director Ramesh Kunhikannan—Kaynes' founder and promoter holding 53.52% stake—stepping in interim. Kunhikannan, a serial entrepreneur who bootstrapped Kaynes from a garage in 1988, praised Sharma as a "visionary partner" in a board statement, assuring continuity. Yet, the timing—post-Q1 FY26 results showing a 30% sequential revenue dip to ₹700 crore—has fueled speculation of strategic divergences.
In his letter, Sharma emphasized personal growth: "At this juncture, I believe it is time for me to explore fresh challenges." No golden parachute details were disclosed, but SEBI norms mandate transparency on severance for key managerial personnel. This marks the second high-profile exit in 2025; Deputy CFO R. Balasubramanian resigned in January for "personal reasons," and IT Head Govind S. Menokee followed in August. While not indicative of systemic churn, it underscores the talent war in EMS, where poaching by giants like Tata Electronics is rampant.
Immediate Market Reaction: Shares Plunge Amid Broader Sell-Off
Kaynes' shares opened flat on September 19 but cascaded 4.78% to an intraday low of ₹6,882 by 11:36 AM IST—the steepest single-day drop since a 9% tumble in March 2025 following a SEBI show-cause notice to MD Ramesh Kunhikannan over insider trading lapses in FY23 financials. Trading volume spiked 2.5 times the 20-day average at 1.2 million shares, with FIIs offloading 0.46% stake (now at 10.71%) and DIIs (including mutual funds at 18.91%) holding steady. The stock recovered marginally to close at ₹6,940, down 4.4% from ₹7,257, but the day's volatility erased ₹2,450 crore in market value, pushing cap below ₹47,000 crore from a peak of ₹55,000 crore in July.
This plunge mirrored small-cap malaise: The Nifty Smallcap 100 index shed 1.2%, extending a five-session losing streak amid FII outflows of $1.2 billion in September, driven by US Fed rate cut delays and China's economic slowdown. Sector peers weren't spared—Dixon Technologies dipped 2.1%, Amber Enterprises 1.8%—but Kaynes' fall was outsized, with put options at ₹7,000 strike surging 40% in open interest. Analysts attributed 60% of the drop to resignation jitters, 40% to macro headwinds like a 15% YoY dip in auto sector orders.
Post-market, CFO Jairam Paravathavarthanarayana addressed concerns in a con-call snippet: "We are in advanced talks for a successor, to be announced by mid-October. Rajesh's departure is amicable; our FY26 guidance remains intact at 40% revenue growth." This quelled some panic, with shares rebounding 1.5% in after-hours trade. Yet, brokerage reactions were mixed: Prabhudas Lilladher retained a "hold" at ₹6,367 (down from ₹6,500), citing leadership vacuum risks, while Motilal Oswal stayed "buy" at ₹8,200, emphasizing a robust ₹5,200 crore order book.
Company Background: Kaynes' Rise in India's EMS Landscape
Founded in 1988 by Ramesh Kunhikannan in Mysore, Karnataka, Kaynes Technology India Limited started as a PCB assembly unit for consumer electronics. By 2008, it pivoted to integrated EMS, serving automotive (30% revenue), industrial (25%), aerospace/defense (20%), and emerging IoT/medical (25%). Incorporated as a public entity in 2008, Kaynes went public in 2021, raising ₹667 crore at ₹715-₹715 per share—a 184% pop on listing amid PLI euphoria.
Today, with 3,851 employees across eight facilities (including Sanand and Hyderabad), Kaynes boasts end-to-end capabilities: design, prototyping, NPI, and volume manufacturing. Key clients include Honeywell (aerospace), Bosch (auto), and L&T (defense), with exports at 15% of revenue. The September 6, 2025, integration of Mustard Smartglasses' AI-AR team bolsters its ODM/OEM edge in wearables. Promoter Kunhikannan (53.52% stake) and Chairperson Savitha Ramesh (family holding) anchor stability, with MH Prasad as Co-CEO providing operational continuity.
Kaynes' FY25 was stellar: Consolidated revenue hit ₹4,500 crore (up 58% YoY), net profit ₹317 crore (66% growth), EBITDA ₹600 crore (13.78% margin). Q1 FY26 softened to ₹700 crore revenue (31% YoY up but 30% QoQ down) and ₹74 crore profit (47% YoY), blamed on seasonal auto slumps. Debt stands at ₹1,200 crore (gearing 0.4x), with ₹800 crore cash for capex. PLI allocations—₹1,700 crore for OSAT (Outsourced Semiconductor Assembly and Test)—position Kaynes for India's $300 billion electronics target by 2026.
Financial Snapshot: Resilience Amid Volatility
Kaynes' balance sheet gleams despite the blip. As of June 30, 2025, consolidated total income was ₹700.56 crore (down 30% QoQ from ₹1,005 crore but up 32% YoY from ₹532 crore), with net profit at ₹74.61 crore (47% YoY jump). PBDT rose 54% to ₹111.7 crore, OPM dipped to 13.78% from 13.27%. For FY25 full year, sales soared 50% to ₹1,915 crore, profit 66% to ₹210 crore.
Valuations reflect premium: P/E at 123x (vs. sector 45x), P/B 16.5x, EV/EBITDA 50x—pricing in 40% CAGR to FY28. Order book at ₹5,200 crore (18 months visibility) spans ₹2,000 crore defense (DMS order), ₹1,500 crore auto, and ₹1,700 crore industrial. Capex of ₹2,000 crore FY26 targets 20% capacity hike, funded by ₹1,000 crore internal accruals and ₹1,000 crore debt.
Challenges persist: Q1 revenue dip signals auto cyclicality (Mahindra slowdown), while forex gains masked 5% margin erosion from component costs. No dividends yet—profits reinvested—irks yield hunters, but ROE at 25% justifies growth focus.
Broader Market Context: Turbulence in EMS and Small-Caps
September 2025's market storm—Nifty down 2.5% MTD—stems from FII outflows ($2.5 billion YTD), US election jitters, and China's deflationary exports denting EMS demand. The sector, valued at $20 billion, faces headwinds: Global chip shortage eases but tariffs loom (US-China trade war redux). Peers like Dixon (down 15% YTD) and Syrma SGS (flat) mirror Kaynes' woes, but PLI inflows ($10 billion committed) buoy sentiment.
Small-caps, up 25% in 2025 pre-August correction, now correct 10% on valuation froth (Nifty Smallcap P/E 32x vs. large-cap 22x). Kaynes' drop fits this: High-beta stock (1.5) amplifies indices' 0.5% dip. Positive offsets: RBI's September 10 repo cut to 6.25% eases borrowing, while "China+1" shifts ($50 billion FDI inflows) favor EMS.
Analyst Perspectives: Hold to Buy Amid Uncertainty
Wall Street's take is cautiously optimistic. Of 23 analysts, 17 rate "buy" (target ₹7,500 avg., 8% upside), five "hold" (₹6,800), one "sell." Prabhudas Lilladher (hold, ₹6,367): "Leadership transition risks execution; monitor successor." Motilal Oswal (buy, ₹8,200): "Order book, PLI tailwinds outweigh churn." ICICI Securities (buy, ₹7,900): "Q2 rebound expected at 45% YoY revenue."
Consensus FY26 EPS: ₹55 (up 40%), implying P/E 126x—stretched but justified by 25% ROCE. Risks flagged: 20% downside if auto demand slumps 10%.
Future Outlook: Transition Challenges and Growth Catalysts
October 31 looms as a pivot: Successor search—internal like Co-CEO MH Prasad or external from Foxconn/Tata—will dictate stability. Kunhikannan's interim role reassures, given his founder vision. Short-term, shares could test ₹6,500 support; rebound to ₹7,500 if Q2 beats (October earnings).
Long-term, catalysts abound: ₹5,200 crore orders execution yields 40% growth; Sanand OSAT ramps to ₹1,000 crore revenue by FY27; AR/AI push via Mustard integration taps $10 billion wearables market. PLI disbursals (₹500 crore FY26) fund debt reduction. Risks: Geopolitical flares (Taiwan), margin squeeze (raw materials up 8%).
Kaynes' story is one of resilience: From ₹3,500 crore IPO to ₹50,000 crore cap, Sharma's legacy endures. The drop? A turbulence blip in a high-altitude flight.
Conclusion
Rajesh Sharma's resignation on September 19, 2025, jolted Kaynes Technology, sending shares into a 4% tailspin amid market headwinds—a stark reminder of leadership's sway in volatile sectors. Yet, beneath the turbulence lies a robust engine: Surging orders, PLI firepower, and Kunhikannan's steady hand. As analysts hold steady on buys, Kaynes isn't derailed—it's recalibrating for takeoff. In EMS's high-stakes arena, this dip could be the buy signal savvy investors await, propelling the stock toward ₹8,000 by FY26 end. Sharma's exit closes a chapter; the next, under new stewardship, promises even bolder narratives
.png)
.png)
0 Comments